"The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin], enoxaparin [Lovenox]) and factor Xa inhibitors (fondaparinux [Arixtra]).
In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism."
Scope of the Report:
This report focuses on the Injectable Anticoagulants in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Request For Sample Report @ https://www.fiormarkets.com/report-detail/105706/request-sample
Market Segment by Manufacturers, this report covers
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Access Full Report With TOC @ http://www.fiormarkets.com/report/global-north-america-europe-and-asia-pacific-south-america-105706.html
Market Segment by Type, covers
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Market Segment by Applications, can be divided into
VTE
ACS/MI
AF
Other
There are 15 Chapters to deeply display the global Injectable Anticoagulants market.
Chapter 1, to describe Injectable Anticoagulants Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Injectable Anticoagulants, with sales, revenue, and price of Injectable Anticoagulants, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Injectable Anticoagulants, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Injectable Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Injectable Anticoagulants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: [email protected]
Web: www.fiormarkets.com
Blog: www.albaniantimes.com
Warning! This user is on my black list, likely as a known plagiarist, spammer or ID thief. Please be cautious with this post!
To get off this list, please chat with us in the #steemitabuse-appeals channel in steemit.chat.
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit